Literature DB >> 34726754

Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.

Amy C Sherman1,2,3, Michaël Desjardins1,2,4, Chi An Cheng5,6,3, Bruce Bausk1, Natalie Izaguirre1,2, Guohai Zhou1, Jonathan Krauss1, Nicole Tolan5,3, David R Walt5,6,3, Robert Soiffer2, Vincent T Ho2, Nicolas C Issa1,2,3, Lindsey R Baden1,2,3.   

Abstract

The severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine-induced humoral response and reactogenicity profile are described in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Findings showed that 75.0% (by Simoa assay) or 80.0% (by Roche assay) of the HSCT cohort had a positive antibody response on series completion, compared with 100% in the healthy cohort.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  SARS-CoV-2; immunocompromised; immunogenicity; mRNA vaccines

Mesh：

Substances：

Year:  2022        PMID： 34726754      PMCID： PMC8689898          DOI： 10.1093/cid/ciab930

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


  7 in total

Review 1.  A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies.

Authors:  Maryam Noori; Shadi Azizi; Farhan Abbasi Varaki; Seyed Aria Nejadghaderi; Davood Bashash
Journal:  Int Immunopharmacol       Date:  2022-07-12       Impact factor: 5.714

2.  Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review.

Authors:  Vanessa Piechotta; Sibylle C Mellinghoff; Caroline Hirsch; Alice Brinkmann; Claire Iannizzi; Nina Kreuzberger; Anne Adams; Ina Monsef; Jannik Stemler; Oliver A Cornely; Paul J Bröckelmann; Nicole Skoetz
Journal:  Blood Cancer J       Date:  2022-05-31       Impact factor: 9.812

3.  Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.

Authors:  Ainsley Ryan Yan Bin Lee; Shi Yin Wong; Louis Yi Ann Chai; Soo Chin Lee; Matilda Xinwei Lee; Mark Dhinesh Muthiah; Sen Hee Tay; Chong Boon Teo; Benjamin Kye Jyn Tan; Yiong Huak Chan; Raghav Sundar; Yu Yang Soon
Journal:  BMJ       Date:  2022-03-02

4.  Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant.

Authors:  Sam M Murray; Maria Barbanti; Cori Campbell; Anthony Brown; Lucia Chen; Jay Dhanapal; Bing Tseu; Omer Pervaiz; Louis Peters; Sally Springett; Robert Danby; Sandra Adele; Eloise Phillips; Tom Malone; Ali Amini; Lizzie Stafford; Alexandra S Deeks; Susanna Dunachie; Paul Klenerman; Andrew Peniket; Eleanor Barnes; Murali Kesavan
Journal:  Br J Haematol       Date:  2022-06-22       Impact factor: 8.615

5.  Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies.

Authors:  Amy C Sherman; Jennifer L Crombie; ChiAn Cheng; Michaël Desjardins; Guohai Zhou; Omolola Ometoruwa; Rebecca Rooks; Yasmeen Senussi; Mikaela McDonough; Liliana I Guerrero; John Kupelian; Simon Doss-Gollin; Kinga K Smolen; Simon D van Haren; Philippe Armand; Ofer Levy; David R Walt; Lindsey R Baden; Nicolas C Issa
Journal:  Open Forum Infect Dis       Date:  2022-08-16       Impact factor: 4.423

6.  Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation.

Authors:  Ok-Kyong Chaekal; Alexandra Gomez-Arteaga; Zhengming Chen; Rosemary Soave; Tsiporah Shore; Sebastian Mayer; Adrienne Phillips; Jing Mei Hsu; Alexander Drelick; Rosy Priya L Kodiyanplakkal; Markus Plate; Michael J Satlin; Koen van Besien
Journal:  Transplant Cell Ther       Date:  2022-06-18

7.  Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation.

Authors:  Toshiyuki Ueno; Takanori Ohta; Yasuhiro Sugio; Yuju Ohno; Yasufumi Uehara
Journal:  Bone Marrow Transplant       Date:  2022-03-10       Impact factor: 5.174
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.